Mood drugs.
D000014:Abnormalities, Drug-Induced; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D001714:Bipolar Disorder / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D002648:Child; D003863:Depression / Q000188:drug therapy; D004347:Drug Interactions; D004565:Electroconvulsive Therapy; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D006973:Hypertension / Q000139:chemically induced; D008094:Lithium / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy
D000929:Antidepressive Agents, Tricyclic; D000697:Central Nervous System Stimulants; D008996:Monoamine Oxidase Inhibitors; D008094:Lithium